In 2023, after a brief hiatus, tuberculosis regained from COVID its status as the world’s deadliest infectious disease—a ...

HIV/AIDS continues to disproportionately affect Black Americans, despite overall progress in reducing infection rates.

Human rights, key and vulnerable populations Ethiopia received PEPFAR funding for work on stigma, discrimination and enabling legal environments. As a result of the USG stop-work order, all programmes ...

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

Nearly half of all new cases in 2022 were in the South. "The frustrating part is we have the tools now to stop it." ...

An annual shot to protect against HIV infection has successfully passed an early safety trial, according to research ...

A clinical trial suggests Lenacapavir, a yearly injection, could revolutionise HIV prevention by offering long-term protection, simplifying adherence, and expanding access to at-risk populations.

Kisumu leads with 135,550 cases, followed by Homa Bay (109,786), Migori (106,003), Siaya (93,368), and Nairobi (82,820).

In the general population, frailty is an aging-related risk factor for poor outcomes; individuals experiencing frailty face ...

During the opening day of the Conference on Retroviruses and Opportunistic Infections, Rebecca Denison, a decades-long HIV ...

PEPFAR, a global program to combat AIDS, faces an existential threat due to partisan politics, but Congress has an opportunity to reform the program and ensure its continued success.

The advent of effective antiretroviral therapy (ART) has increased the lifespan of many people living with HIV. As a result, ...